MedPath

ALLERGAN AUSTRALIA PTY LIMITED

🇦🇺Australia
Ownership
-
Employees
-
Market Cap
-
Website

Safety and Efficacy Study of Dexamethasone in the Treatment of Patients With Macular Edema Following Retinal Vein Occlusion (RVO)

Phase 3
Completed
Conditions
Macular Edema
Interventions
First Posted Date
2012-08-09
Last Posted Date
2019-04-17
Lead Sponsor
Allergan
Target Recruit Count
262
Registration Number
NCT01660802

A Pharmacokinetic Study of MK-1602 in the Treatment of Acute Migraine (MK-1602-007)

Phase 2
Completed
Conditions
Migraine
Interventions
Drug: Placebo
Drug: Rescue medication
First Posted Date
2012-08-06
Last Posted Date
2016-12-09
Lead Sponsor
Allergan
Target Recruit Count
195
Registration Number
NCT01657370

A Prospective, Observational Study of Patients With Cervical Dystonia (Dystonie) Treated With OnabotulinumtoxinA

Completed
Conditions
Torticollis
Interventions
Biological: OnabotulinumtoxinA
First Posted Date
2012-08-02
Last Posted Date
2017-03-30
Lead Sponsor
Allergan
Target Recruit Count
62
Registration Number
NCT01655862
Locations
🇨🇦

Centre Medical Le Mesnil, Quebec, Canada

🇨🇦

CHU de Québec, Hôpital de l'Enfant-Jésus, Quebec, Canada

🇨🇦

Clinique Neuro-Rive Sud, Greenfield Park, Quebec, Canada

and more 5 locations

Chronic Migraine Epidemiology and Outcomes Study

Completed
Conditions
Migraine Disorders
Interventions
Other: No Treatment
First Posted Date
2012-07-24
Last Posted Date
2015-01-29
Lead Sponsor
Allergan
Target Recruit Count
16789
Registration Number
NCT01648530

A Study Comparing IOP-Lowering Treatments to Bimatoprost in Patients With Primary Open Angle Glaucoma or Ocular Hypertension

Completed
Conditions
Ocular Hypertension
Glaucoma, Open-Angle
Interventions
First Posted Date
2012-07-20
Last Posted Date
2014-06-13
Lead Sponsor
Allergan
Target Recruit Count
2580
Registration Number
NCT01646151

European New Texture Implant Clinical Experience With Shaped Breast Implants

Phase 4
Completed
Conditions
Breast Augmentation
Interventions
Device: new texture shaped breast implants
First Posted Date
2012-07-13
Last Posted Date
2017-11-30
Lead Sponsor
Allergan
Target Recruit Count
19
Registration Number
NCT01639755
Locations
🇸🇪

Klinik 34, Göteburg, Sweden

🇸🇪

Akademikliniken 10, Stockholm, Sweden

European New Texture Implant Clinical Experience With Round Breast Implants

Not Applicable
Completed
Conditions
Breast Augmentation
Interventions
Device: New texture round breast implants
First Posted Date
2012-07-13
Last Posted Date
2017-11-30
Lead Sponsor
Allergan
Target Recruit Count
18
Registration Number
NCT01639742
Locations
🇩🇪

Malteser Krankenhaus, Bonn, Germany

🇸🇪

Akademikliniken 10, Stockholm, Sweden

🇩🇪

Praxisklinik Siepe Friedrichstraße 57, Bonn, Germany

and more 1 locations

A Study of Patients With Primary Open Angle Glaucoma or Ocular Hypertension Who Were Insufficiently Responsive to Monotherapy

Completed
Conditions
Ocular Hypertension
Glaucoma, Open-Angle
Interventions
Drug: Any Fixed Combination Therapy
First Posted Date
2012-07-11
Last Posted Date
2012-09-21
Lead Sponsor
Allergan
Target Recruit Count
4385
Registration Number
NCT01637246

Study of Inter- and Intra-rater Reliability of the Clinician Erythema Assessment Scale

Completed
Conditions
Rosacea
Erythema
Interventions
First Posted Date
2012-07-10
Last Posted Date
2019-11-18
Lead Sponsor
Allergan
Target Recruit Count
104
Registration Number
NCT01636765

A Study of AGN-195263 for the Treatment of Meibomian Gland Dysfunction

Phase 2
Completed
Conditions
Meibomian Gland Dysfunction
Interventions
Drug: AGN-195263 0.1%
Drug: AGN-195263 0.03%
Drug: AGN-195263 0.01%
Drug: AGN-195263 Vehicle
First Posted Date
2012-07-04
Last Posted Date
2017-09-08
Lead Sponsor
Allergan
Target Recruit Count
232
Registration Number
NCT01633788
Locations
🇺🇸

Virginia Eye Consultants, Norfolk, Virginia, United States

🇺🇸

Ophthalmic Consultants Long Island, Rockville Centre, New York, United States

🇺🇸

Wohl Eye Center, Bloomingdale, Illinois, United States

and more 30 locations
© Copyright 2025. All Rights Reserved by MedPath